author-photo

Tsila Zuckerman

Rambam Health Care Campus
Rappaport Faculty of Medicine

65

Papers

243

Citations

Citation Trend

Filter By

Papers (49) Sort By

Journal Conference Others

In Patients with Acute Myeloid Leukemia, Hidac Administered on Days 1, 2 and 3 of Consolidation Course Is As Efficacious As Hidac Given on Days 1, 3 and 5, but Is Better Tolerated

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Real-World Management of Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax-Based Regimens: Results from the AML Real World Evidence (ARC) Initiative

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Attenuated humoral immune response following anti-SARS-CoV-2 vaccine in heavily-pretreated patients with multiple myeloma and AL amyloidosis.

2021 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of aspacytarabine (BST-236) as a single-agent, first-line therapy for patients with acute myeloid leukemia unfit for standard chemotherapy.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment.

2021 Acta Haematologica
Show All
- Source
- Cite
- Save
Citations (1)
Comparative Effectiveness of Venetoclax Combinations Vs Other Therapies Among Patients with Newly Diagnosed Acute Myeloid Leukemia: Results from the AML Real World Evidence (ARC) Initiative

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission

2020 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (5)
Durable Remissions and Increased Overall Survival in AML Patients Deemed Unfit for Standard Intensive Chemotherapy Achieved with High-Dose BST-236 (Aspacytarabine) Induction and Consolidation

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Daratumumab after Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Safety and Efficacy. a Retrospective Study from the Cmwp EBMT

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT

2020 Blood
Show All
- Source
- Cite
- Save
Citations (2)